Deerfield Management Company, L.P. (Series C) Insmed Inc Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Insmed Inc stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 52,861 shares of INSM stock, worth $3.7 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
52,861
Previous 11,359
365.37%
Holding current value
$3.7 Million
Previous $761,000
406.96%
% of portfolio
0.07%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding INSM
# of Institutions
467Shares Held
182MCall Options Held
2.27MPut Options Held
3.33M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$999 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$881 Million0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$735 Million62.32% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$457 Million0.09% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.48B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...